Application 215556
- Type
- ANDA
- Sponsor
- VKT PHARMA
Application Products#
| Product | Drug | Ingredient | Form | Strength | Reference drug | Reference standard |
|---|---|---|---|---|---|---|
| 001 | TADALAFIL | TADALAFIL | TABLET;ORAL | 2.5MG | No | No |
| 002 | TADALAFIL | TADALAFIL | TABLET;ORAL | 5MG | No | No |
| 003 | TADALAFIL | TADALAFIL | TABLET;ORAL | 10MG | No | No |
| 004 | TADALAFIL | TADALAFIL | TABLET;ORAL | 20MG | No | No |
NDC Listings For This Application#
| NDC | Name | Nonproprietary name | Labeler | Marketing category | Status |
|---|---|---|---|---|---|
| 71821-006 | tadalafil | Tadalafil | VKT Pharma Private Limited | ANDA | Current |
| 71821-007 | tadalafil | Tadalafil | VKT Pharma Private Limited | ANDA | Current |
| 71821-008 | tadalafil | Tadalafil | VKT Pharma Private Limited | ANDA | Current |
| 71821-009 | tadalafil | Tadalafil | VKT Pharma Private Limited | ANDA | Current |